review Open AccessTop 1% cited
Delivery technologies for cancer immunotherapy
Nature Reviews Drug Discovery · 2019 · Vol. 18(3) · pp. 175–196
Rachel Riley(University of Pennsylvania)Carl H. June(University of Pennsylvania)Róbert Langer✉(Massachusetts Institute of Technology)Michael J. Mitchell(University of Pennsylvania)
Immunotherapy and Immune ResponsesCAR-T cell therapy researchCancer Immunotherapy and BiomarkersImmunotherapyCancer immunotherapyMedicineCancerAdverse effectDrug deliveryImmune systemClinical trialDrugImmunology
MeSH terms
AnimalsHumansImmunotherapyNeoplasmsT-LymphocytesDrug Delivery SystemsNanoparticles
Citations
2,556
FWCI
105.98
field-weighted impact
References
265
Percentile
100%
vs. same field & year
Citations per year
Cited by
Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency
Advanced Science · 2022 · 620 citations
Application of Nanomaterials in Biomedical Imaging and Cancer Therapy
Nanomaterials · 2020 · 380 citations
Engineering precision nanoparticles for drug delivery
Nature Reviews Drug Discovery · 2020 · 6,985 citations
Top 10 Challenges in Cancer Immunotherapy
Immunity · 2020 · 2,223 citations
A guide to cancer immunotherapy: from T cell basic science to clinical practice
Nature reviews. Immunology · 2020 · 4,024 citations
References
Knocking down barriers: advances in siRNA delivery
Nature Reviews Drug Discovery · 2009 · 3,091 citations
Cancer immunotherapy: moving beyond current vaccines
Nature Medicine · 2004 · 2,953 citations
Cytokines in Cancer Immunotherapy
Cancers · 2011 · 677 citations
Toxicity of cationic lipids and cationic polymers in gene delivery
Journal of Controlled Release · 2006 · 2,215 citations
Interleukin-12 and the regulation of innate resistance and adaptive immunity
Nature reviews. Immunology · 2003 · 3,858 citations
PLGA-based nanoparticles: An overview of biomedical applications
Journal of Controlled Release · 2012 · 3,552 citations
Non-viral vectors for gene-based therapy
Nature Reviews Genetics · 2014 · 3,038 citations
A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian Cancer
Clinical Cancer Research · 2006 · 1,233 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.